ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
50
PROTECTION OF CLINICAL TRIAL PARTICIPANTS' RIGHTS:
ETHICAL AND LEGAL STANDARDS
Toshmatova Visolakhon Ikrom kizi
Independent researcher of University of World
Economy and Diplomacy
E-mail: visolka1202@gmail.com
https://doi.org/10.5281/zenodo.13729498
Clinical trials play a crucial role in the development of medicine by enabling
the creation of new drugs, treatment methods, and medical technologies.
However, their conduct involves certain risks for participants, emphasizing the
importance of ethical and legal standards that ensure the protection of the rights
and interests of people who voluntarily participate in these studies. In recent
decades, clinical trial standards have evolved significantly, incorporating stricter
ethical rules and the adoption of international legal norms aimed at protecting
participants. This article will explore the topic of protecting the rights of clinical
trial participants, including key ethical and legal standards that exist today.
The primary goal of clinical trials is to obtain new scientific data to improve
treatment quality. It is essential to balance scientific interests and the safety of
participants. Every stage of the research must comply with both legal and ethical
requirements, which are established at the national and international levels.
Clinical trials, involving human health and life, must be conducted in strict
accordance with ethical norms. These principles are aimed at ensuring respect
for the rights and dignity of research participants. The essential ethical
standards include:
1.
The Principle of Autonomy
: One of the core principles of ethics in
clinical research is respect for the autonomy of participants. This means that
participants must independently decide whether to participate in the trial, based
on complete and clear information provided by the researchers. Informed
consent plays a crucial role here: the participant must clearly understand the
objectives, methods, potential risks, and benefits of the study, and have the
opportunity to withdraw at any time.
2.
The Principle of Non-Maleficence
: This principle requires
researchers to minimize risks for participants. Any intervention that involves
health risks must be carefully weighed, and potential harmful consequences
should be minimized. Clinical trials should not cause harm to participants that
exceeds potential benefits to society.
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
51
3.
The Principle of Beneficence
: Researchers must strive to maximize
the benefit for participants. All studies should be aimed at improving existing
treatment methods or developing new ones that can significantly enhance
patients' quality of life.
4.
The Principle of Justice
: Clinical trial participants must not face
discrimination based on age, gender, social status, or other factors. The
distribution of benefits and risks among participants must be fair, and the
selection of individuals for research should be ethically justified and
appropriate.
5.
Confidentiality and Data Protection
: An important ethical
requirement is the confidentiality of participants. Personal data and health
information must be securely protected, and access to them should be strictly
limited.
In addition to ethical principles, there are several legal norms that ensure
the protection of clinical trial participants. These standards are enshrined in
national laws and international documents, such as the Declaration of Helsinki,
the Nuremberg Code, and Good Clinical Practice (GCP) standards.
1.
The Declaration of Helsinki
: Adopted by the World Medical
Association in 1964, the Declaration of Helsinki is one of the most important
documents governing clinical trials. It outlines the main principles of protecting
research participants, including the requirements for informed consent and
minimizing risks.
2.
The Nuremberg Code
: Developed in 1947 after World War II, this
document became one of the first international acts regulating medical
experiments on humans. It enshrines the principle of voluntary participation in
research and the need for informed consent.
3.
Good Clinical Practice (GCP)
: The GCP standard was developed by
the International Council for Harmonisation (ICH) and is fundamental for clinical
trials. This document regulates all aspects of conducting clinical research,
including participants' rights, safety requirements, and researchers'
responsibilities. GCP ensures that clinical trials are conducted in compliance
with all necessary legal and ethical norms.
4.
National Legislation
: Every country has its own laws and
regulations governing clinical trials. For example, in the European Union, clinical
trials are regulated by EU Regulation No. 536/2014, which sets clear
requirements for informing participants, risk management, and trial monitoring.
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
52
5.
Right to Compensation and Medical Assistance
: Clinical trial
participants who suffer harm during the study are entitled to compensation and
medical care. This aspect is regulated by both international documents and
national laws, providing an important guarantee of participants' rights.
Clinical trials are often conducted in multiple countries simultaneously,
requiring international cooperation and the unification of standards. To ensure
the protection of participants' rights on a global scale, international agreements
and recommendations are developed.
1.
International Council for Harmonization (ICH)
: ICH is a key
organization that develops standards for clinical trials, including GCP. These
standards are applied in many countries and are mandatory for conducting
international research.
2.
The Role of the World Health Organization (WHO)
: The WHO
actively participates in the development and promotion of international
standards for clinical trials, especially in low- and middle-income countries,
where new drug trials are often conducted.
3.
Ethics Committees and Their Role
: To monitor the ethical aspects
of clinical trials internationally, specialized ethics committees have been
established. These committees evaluate research projects in terms of
participants' rights protection, risk minimization, and compliance with GCP
standards.
The key mechanisms for protecting participants' rights include:
1.
Informed Consent
: A crucial mechanism for protecting participants'
rights is the process of obtaining informed consent. Participants must receive
complete information about the objectives, methods, and potential risks of the
study, and they must have the opportunity to ask questions and withdraw from
participation at any time without negative consequences.
2.
Ethical Oversight
: All clinical trials must undergo ethical review
before they begin. Ethics committees evaluate research protocols regarding
potential risks, fairness in participant selection, and compliance with ethical
norms.
3.
Monitoring and Auditing
: An important element in protecting
participants' rights is the monitoring and auditing of clinical trials. Competent
authorities and independent auditors ensure that the research complies with
established standards and verify whether participants' rights are upheld.
4.
Complaints and Compensation Mechanisms
: It is important that
participants have the opportunity to file complaints if their rights are violated
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
53
during the study. In this case, they are entitled to compensation as well as legal
assistance.
Thus, protecting the rights of clinical trial participants is one of the most
critical tasks in medicine and pharmaceuticals. Ethical and legal standards
developed at the international level are aimed at ensuring the safety and respect
of participants' dignity, as well as the fair distribution of risks and benefits.
Compliance with these standards is key to public trust in clinical trials and their
outcomes.
A vital part of these standards is informed consent, ensuring conscious and
voluntary participation in studies. Ethical oversight and monitoring help
minimize risks and protect participants. In the context of globalization and the
growing international collaboration in clinical trials, the unification of legal and
ethical norms becomes particularly relevant. Only by adhering to all these
principles can clinical trials become an effective and safe tool for developing new
treatments and improving public health worldwide.
References:
1.
World Medical Association. (1964). Declaration of Helsinki: Ethical
Principles for Medical Research Involving Human Subjects. World Medical
Association.
Available
at:
https://www.wma.net/policies-post/wma-
declaration-of-helsinki-ethical-principles-for-medical-research-involving-
human-subjects/
2.
Nuremberg Code. (1947). Trials of War Criminals before the Nuremberg
Military Tribunals under Control Council Law No. 10, Vol. 2. U.S. Government
Printing Office. Available at: https://www.hhs.gov/ohrp/regulations-and-
policy/belmont-report/index.html
3.
ICH Harmonised Guideline. (2016). Good Clinical Practice (GCP) E6(R2).
International Council for Harmonisation of Technical Requirements for
Pharmaceuticals for Human Use. Available at: https://ichgcp.net/
4.
European Union Regulation. (2014). EU Regulation No 536/2014 on
Clinical Trials on Medicinal Products for Human Use. Available at: https://eur-
lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014R0536
5.
World Health Organization. (2011). Standards and Operational Guidance
for Ethics Review of Health-Related Research with Human Participants. WHO
Press. Available at: https://apps.who.int/iris/handle/10665/44783
6.
Council for International Organizations of Medical Sciences (CIOMS).
(2016). International Ethical Guidelines for Health-related Research Involving
Humans. Available at: https://cioms.ch/publications/product/international-
ethical-guidelines-for-health-related-research-involving-humans/
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
54
7.
US Food and Drug Administration. (1997). ICH Guidance for Industry: E6
Good
Clinical
Practice:
Consolidated
Guidance.
Available
at:
https://www.fda.gov/regulatory-information/search-fda-guidance-
documents/e6r2-good-clinical-practice-integrated-addendum-consolidated-
guidance
8.
Council of Europe. (1997). Convention on Human Rights and Biomedicine
(Oviedo Convention). Available at:
https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164
9.
Lemmens, T., & Freedman, B. (2000). Ethics Review for Sale? Conflict of
Interest and Commercial Research Review Boards. Milbank Quarterly, 78(4),
547-584.
10.
Shamoo, A. E., & Resnik, D. B. (2009). Responsible Conduct of Research
(2nd ed.). Oxford University Press.
11.
Manson, N. C., & O'Neill, O. (2007). Rethinking Informed Consent in
Bioethics. Cambridge University Press.
12.
UNESCO. (2005). Universal Declaration on Bioethics and Human Rights.
Available at:
https://en.unesco.org/themes/ethics-science-and-
technology/bioethics-and-human-rights
